IESE (España)
-
A New Model for the Pharmaceutical Industry: The Institute of OneWorld Health
Schoen, Oliver; Mair, JohannaCase DG-1480-EEntrepreneurship, Innovation and ChangeThis case introduces the Institute of OneWorld Health, a company dedicated to producing drugs for neglected diseases and the first non-profit pharmaceutical company in the world. Founded in 2000 by Dr. Victoria Hale, IOWH took expired and donated patent compounds and developed them through all the stages of clinical testing and approval into drugs to fight the world's most destructive diseases, usually occurring in Third World countries where per...Starting at €8.20
-
Basel II: The New Framework for Bank and Company Relations
Rahnema Alavi, Ahmad; Soley, JorgeTechnical Note FN-526-EFinanceOn June 26th, 2004, the Basel Committee on Banking Supervision published the final version of Basel II, its new capital adequacy framework for banks, which is intended to come into force in stages from the end of 2006. A key issue in shaping Basel II is the implication of the new rules concerning the access to and terms of bank credit for companies, with specific focus on small and medium size enterprises (SMEs). The objective of this technical ...Starting at €8.20
-
Basilea II: El nuevo marco de relaciones para la banca y las empresas
Rahnema Alavi, Ahmad; Soley, JorgeTechnical Note FN-526FinanceEl 26 de junio de 2004, el comité de Basilea de supervisión bancaria publicó la versión final de Basilea II, su nueva estructura de adecuación de capital para bancos, la cual estaba previsto que entrara en vigor en etapas a partir de finales de 2006. Un punto clave para Basilea II es la implicación de nuevas reglas en relación al acceso y los términos de crédito bancario para empresas, con un foco específico en empresas de pequeña y mediana enver...Starting at €8.20